메뉴 건너뛰기




Volumn 32, Issue 7, 2012, Pages 1260-1264

Time to first treatment: The significance of early treatment of exudative age-related macular degeneration

Author keywords

age related macular degeneration; choroidal neovascularization; duration of symptoms; ranibizumab

Indexed keywords

RANIBIZUMAB;

EID: 84862847569     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182018df6     Document Type: Article
Times cited : (50)

References (17)
  • 1
  • 2
    • 0031695623 scopus 로고    scopus 로고
    • Age-specific prevalence and causes of blindness and visual impairment in an older population: The Rotterdam study
    • Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653-658. (Pubitemid 28414581)
    • (1998) Archives of Ophthalmology , vol.116 , Issue.5 , pp. 653-658
    • Klaver, C.C.W.1    Wolfs, R.C.W.2    Vingerling, J.R.3    Hofman, A.4    De Jong, P.T.V.M.5
  • 3
    • 0034788401 scopus 로고    scopus 로고
    • A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and e and beta carotene for age-related cataract and vision loss: AREDS
    • Age-Related Eye Disease Study Research Group report no. 9
    • Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthal-mol 2001;119:1439-1452.
    • (2001) Arch Ophthal-mol , vol.119 , pp. 1439-1452
  • 4
    • 0027213771 scopus 로고
    • Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization
    • Macular Photocoagulation Study Group
    • Macular Photocoagulation Study Group. Five-year follow-up of fellow eyes of patients with age-related macular degeneration and unilateral extrafoveal choroidal neovascularization. Arch Ophthalmol 1993;111:1189-1199.
    • (1993) Arch Ophthalmol , vol.111 , pp. 1189-1199
  • 5
    • 3242663235 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration
    • DOI 10.1097/00004397-200404430-00005
    • Barouch FC, Miller JW. Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration. Int Ophthalmol Clin 2004;44:23-32. (Pubitemid 38955658)
    • (2004) International Ophthalmology Clinics , vol.44 , Issue.3 , pp. 23-32
    • Barouch, F.C.1    Miller, J.W.2
  • 6
    • 21744446220 scopus 로고    scopus 로고
    • Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration
    • Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 2005;40:352-368. (Pubitemid 40942262)
    • (2005) Canadian Journal of Ophthalmology , vol.40 , Issue.3 , pp. 352-368
    • Ng, E.W.M.1    Adamis, A.P.2
  • 9
    • 69249222585 scopus 로고    scopus 로고
    • A phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration
    • Boyer DS, Heier JS, Brown DM, et al. A phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degeneration. Ophthalmology 2009;116: 1731-1739.
    • (2009) Ophthalmology , vol.116 , pp. 1731-1739
    • Boyer, D.S.1    Heier, J.S.2    Brown, D.M.3
  • 10
    • 0024429725 scopus 로고
    • Growth rate of subretinal neovascularization in age-related macular degeneration
    • discussion 1426-1429
    • Vander JF, Morgan CM, Schatz H. Growth rate of subretinal neovascularization in age-related macular degeneration. Ophthalmology 1989;96:1422-1426; discussion 1426-1429.
    • (1989) Ophthalmology , vol.96 , pp. 1422-1426
    • Vander, J.F.1    Morgan, C.M.2    Schatz, H.3
  • 11
    • 0024454362 scopus 로고
    • Growth features of choroi-dal neovascular membranes in age-related macular degeneration
    • discussion 1420-1421
    • Klein ML, Jorizzo PA, Watzke RC. Growth features of choroi-dal neovascular membranes in age-related macular degeneration. Ophthalmology 1989;96:1416-1419; discussion 1420-1421.
    • (1989) Ophthalmology , vol.96 , pp. 1416-1419
    • Klein, M.L.1    Jorizzo, P.A.2    Watzke, R.C.3
  • 13
    • 80051657930 scopus 로고    scopus 로고
    • Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography
    • Grover S, Murthy RK, Brar VS, Chalam KV. Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography. Invest Ophthalmol Vis Sci 2009.
    • (2009) Invest Ophthalmol Vis Sci
    • Grover, S.1    Murthy, R.K.2    Brar, V.S.3    Chalam, K.V.4
  • 14
    • 33747782925 scopus 로고    scopus 로고
    • Ranibizumab: Phase III clinical trial results
    • DOI 10.1016/j.ohc.2006.05.009, PII S089615490600054X, Ocular Angiogenesis
    • Rosenfeld PJ, Rich RM, Lalwani GA. Ranibizumab: phase III clinical trial results. Ophthalmol Clin North Am 2006;19: 361-372. (Pubitemid 44279358)
    • (2006) Ophthalmology Clinics of North America , vol.19 , Issue.3 , pp. 361-372
    • Rosenfeld, P.J.1    Rich, R.M.2    Lalwani, G.A.3
  • 15
    • 38349172455 scopus 로고    scopus 로고
    • Randomized, double-masked, sham-controlled trial of ranibizumab for neovascu-lar age-related macular degeneration: PIER Study year 1
    • Regillo CD, Brown DM, Abraham P, et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascu-lar age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 2008;145:239-248.
    • (2008) Am J Ophthalmol , vol.145 , pp. 239-248
    • Regillo, C.D.1    Brown, D.M.2    Abraham, P.3
  • 16
    • 33846586501 scopus 로고    scopus 로고
    • Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration
    • DOI 10.1016/j.ophtha.2006.10.045, PII S0161642006014849
    • Boyer DS, Antoszyk AN, Awh CC, et al. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:246-252. (Pubitemid 46172497)
    • (2007) Ophthalmology , vol.114 , Issue.2 , pp. 246-252
    • Boyer, D.S.1    Antoszyk, A.N.2    Awh, C.C.3    Bhisitkul, R.B.4    Shapiro, H.5    Acharya, N.R.6
  • 17
    • 48449085770 scopus 로고    scopus 로고
    • A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations
    • Algvere PV, Steén B, Seregard S, Kvanta A. A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations. Acta Ophthalmol 2008;86:482-489.
    • (2008) Acta Ophthalmol , vol.86 , pp. 482-489
    • Algvere, P.V.1    Steén, B.2    Seregard, S.3    Kvanta, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.